These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 24704330
1. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics]. Navas-López VM, Blasco-Alonso J, Lacasa Maseri S, Girón Fernández-Crehuet F, Serrano Nieto MJ, Vicioso Recio MI, Sierra Salinas C. An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330 [Abstract] [Full Text] [Related]
2. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease. Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ. J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840 [Abstract] [Full Text] [Related]
3. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease. Ong C, Lim PT, Logarajah V, Liwanag MJ, Ang BX, Cher Y, Chiou FK, Kader A. BMC Gastroenterol; 2018 Dec 12; 18(1):185. PubMed ID: 30541458 [Abstract] [Full Text] [Related]
4. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP. Moriczi M, Pujol-Muncunill G, Martín-Masot R, Jiménez Treviño S, Segarra Cantón O, Ochoa Sangrador C, Peña Quintana L, González Santana D, Rodríguez Martínez A, Rosell Camps A, Armas H, Barrio J, González de Caldas R, Rodríguez Salas M, Balmaseda Serrano E, Donat Aliaga E, Bodas Pinedo A, Vaquero Sosa E, Vecino López R, Solar Boga A, Moreno Álvarez A, Sánchez Sánchez C, Tolín Hernani M, Gutiérrez Junquera C, Martinón Torres N, Leis Trabazo MR, Eizaguirre FJ, García Peris M, Medina Benítez E, Fernández Caamaño B, Vegas Álvarez AM, Crespo Valderrábano L, Alonso Vicente C, Rubio Santiago J, Galera-Martínez R, García-Romero R, Ros Arnal I, Fernández Cebrián S, Lorenzo Garrido H, Viada Bris JF, Velasco Rodríguez-Belvis M, Bartolomé Porro JM, Blanco Rodríguez M, Barros García P, Botija G, Chicano Marín FJ, La Orden Izquierdo E, Crehuá-Gaudiza E, Navas-López VM, Martín-de-Carpi J. Nutrients; 2020 Apr 07; 12(4):. PubMed ID: 32272604 [Abstract] [Full Text] [Related]
5. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. J Gastroenterol Hepatol; 2006 Oct 07; 21(10):1609-14. PubMed ID: 16928225 [Abstract] [Full Text] [Related]
6. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis. Yu Y, Chen KC, Chen J. World J Pediatr; 2019 Feb 07; 15(1):26-36. PubMed ID: 30666565 [Abstract] [Full Text] [Related]
10. Exclusive enteral nutrition effect on the clinical course of pediatric Crohn's disease: a single center experience. Scarpato E, Strisciuglio C, Martinelli M, Russo M, Cenni S, Casertano M, Serra MR, Staiano A, Miele E. Eur J Pediatr; 2020 Dec 07; 179(12):1925-1934. PubMed ID: 32734315 [Abstract] [Full Text] [Related]
12. Efficacy of exclusive enteral nutrition in complicated Crohn's disease. Yang Q, Gao X, Chen H, Li M, Wu X, Zhi M, Lan P, Hu P. Scand J Gastroenterol; 2017 Sep 07; 52(9):995-1001. PubMed ID: 28598298 [Abstract] [Full Text] [Related]
14. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis. Connors J, Basseri S, Grant A, Giffin N, Mahdi G, Noble A, Rashid M, Otley A, Van Limbergen J. J Crohns Colitis; 2017 Sep 01; 11(9):1063-1070. PubMed ID: 28575325 [Abstract] [Full Text] [Related]
17. Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study. Cohen-Dolev N, Sladek M, Hussey S, Turner D, Veres G, Koletzko S, Martin de Carpi J, Staiano A, Shaoul R, Lionetti P, Amil Dias J, Paerregaard A, Nuti F, Pfeffer Gik T, Ziv-Baran T, Ben Avraham Shulman S, Sarbagili Shabat C, Sigall Boneh R, Russell RK, Levine A. J Crohns Colitis; 2018 Feb 28; 12(3):306-312. PubMed ID: 29165666 [Abstract] [Full Text] [Related]
19. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease. Copova I, Hradsky O, Zarubova K, Gonsorcikova L, Potuznikova K, Lerchova T, Nevoral J, Bronsky J. Eur J Pediatr; 2018 Nov 28; 177(11):1685-1693. PubMed ID: 30128744 [Abstract] [Full Text] [Related]
20. Exclusive enteral nutrition for inducing remission in inflammatory bowel disease in paediatric patients. Assa A, Shamir R. Curr Opin Clin Nutr Metab Care; 2017 Sep 28; 20(5):384-389. PubMed ID: 28768295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]